洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
试用企业版

【ChiCTR2100051577】Relationship between Estimated Average Glucose (eAG) and Fasting Plasma Glucose- in a Cohort of Pakistani Diabetic Subjects

基本信息
登记号

ChiCTR2100051577

试验状态

结束

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2021-09-27

临床申请受理号

/

靶点

/

适应症

Diabetes

试验通俗题目

Relationship between Estimated Average Glucose (eAG) and Fasting Plasma Glucose- in a Cohort of Pakistani Diabetic Subjects

试验专业题目

Relationship between Estimated Average Glucose (eAG) and Fasting Plasma Glucose- in a Cohort of Pakistani Diabetic Subjects

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

74800

联系人通讯地址
临床试验信息
试验目的

Scientific literature is scarce on the utility of estimated average glucose (eAG) from Pakistan. Hence there is a dire need to evaluate the relationship between eAG and fasting plasma glucose (FPG), in order to enhance our understanding of eAG and its usefulness. This study aims to investigate the relationship between FPG and eAG in diabetic patients calculated using HbA1C.

试验分类
试验类型

连续入组

试验分期

回顾性研究

随机化

all diagnosed cases as per the inclusion exclusion criteria were included

盲法

The identification details of the cases, including the medical record number will be visible only to the PI. In order to ensure security and confidentiality specific study IDs will be assigned by the PI for use by the project team.

试验项目经费来源

None

试验范围

/

目标入组人数

/

实际入组人数

/

第一例入组时间

2013-01-01

试验终止时间

2019-12-31

是否属于一致性

/

入选标准

Previously diagnosed diabetic patients who visited the endocrinology department for treatment follow up from 2013 to 2019, will be recruited for this study.;

排除标准

Exclusion Criteria: Patients with an estimated glomerular filtration rate (eGFR) of less than 60 mL/min/1.73 m2 will be excluded from the study as compromised renal function is known to interfere with HbA1C analysis.;

研究者信息
研究负责人姓名
试验机构

None

研究负责人电话
研究负责人邮箱
研究负责人邮编

74800

联系人通讯地址
<END>

None的其他临床试验

最新临床资讯

对摩熵医药数据库感兴趣,可以免费体验产品

同适应症药物临床试验